These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 12235841

  • 1. [Recent therapeutic strategy for multiple sclerosis].
    Itoyama Y.
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1214-7. PubMed ID: 12235841
    [Abstract] [Full Text] [Related]

  • 2. [Diagnosis and treatment of multiple sclerosis. Update, 2003].
    Jarius S, Hohlfeld R, Voltz R.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():88-91, 93, 95. PubMed ID: 14579493
    [Abstract] [Full Text] [Related]

  • 3. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun 26; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 4. Glatiramer acetate (Copaxone).
    Francis DA.
    Int J Clin Pract; 2001 Jun 26; 55(6):394-8. PubMed ID: 11501229
    [Abstract] [Full Text] [Related]

  • 5. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C, Vukusic S.
    Clin Neurol Neurosurg; 2004 Jun 26; 106(3):263-9. PubMed ID: 15177781
    [Abstract] [Full Text] [Related]

  • 6. [Rationale for an early treatment of multiple sclerosis].
    Comi G, Martino G.
    Rev Neurol; 2004 Jun 26; 30(12):1265-8. PubMed ID: 10935262
    [Abstract] [Full Text] [Related]

  • 7. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P.
    Expert Rev Neurother; 2004 May 26; 4(3):455-63. PubMed ID: 15853542
    [Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH, Javed A.
    Curr Opin Ophthalmol; 2009 Nov 26; 20(6):476-81. PubMed ID: 19816177
    [Abstract] [Full Text] [Related]

  • 9. [New approaches in research of therapy of multiple sclerosis].
    Hemmer B, Cepok S, Nessler S, Sommer N.
    Med Klin (Munich); 2001 Sep 15; 96 Suppl 1():23-8. PubMed ID: 11603112
    [Abstract] [Full Text] [Related]

  • 10. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
    Neuhaus O, Stüve O, Archelos JJ, Hartung HP.
    J Neurol Sci; 2005 Jun 15; 233(1-2):173-7. PubMed ID: 15949504
    [Abstract] [Full Text] [Related]

  • 11. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
    Clerico M, Rivoiro C, Contessa G, Viglietti D, Durelli L.
    Clin Neurol Neurosurg; 2008 Nov 15; 110(9):878-85. PubMed ID: 18164542
    [Abstract] [Full Text] [Related]

  • 12. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T, Bereczki D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):401-16. PubMed ID: 15662768
    [Abstract] [Full Text] [Related]

  • 13. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr 20; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Multiple sclerosis].
    Itoyama Y.
    No To Shinkei; 2000 Dec 20; 52(12):1051-5. PubMed ID: 11193536
    [No Abstract] [Full Text] [Related]

  • 18. Management of multiple sclerosis: current trials and future options.
    Noseworthy JH.
    Curr Opin Neurol; 2003 Jun 20; 16(3):289-97. PubMed ID: 12858064
    [Abstract] [Full Text] [Related]

  • 19. Therapy of multiple sclerosis in children and adolescents.
    Tenembaum SN.
    Clin Neurol Neurosurg; 2010 Sep 20; 112(7):633-40. PubMed ID: 20471159
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.